Regarding diagnosis, an association between the overexpression of APOBEC3A and/or APOBEC3B and certain clinical features in breast cancer, including the absence of ER, PGR, and HER2 receptors, high histological grades, activation of proliferation-related gene sets, and poor clinical outcomes, has been determined. This evidence concerns the gene APOBEC3B and breast cancer.